APA (7th ed.) Citation

PN, S., SJ, C., S, S., HA, H., CA, G., LB, W., . . . AG, S. (2026). Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 202, 119736. https://doi.org/10.1016/j.biopha.2026.119736

Chicago Style (17th ed.) Citation

PN, Song, et al. "Development and Characterization of [47Sc]Sc-NOTA-trastuzumab for Targeted Radiotherapy in Primary and Metastatic HER2 + breast Cancer." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 202 (2026): 119736. https://doi.org/10.1016/j.biopha.2026.119736.

MLA (9th ed.) Citation

PN, Song, et al. "Development and Characterization of [47Sc]Sc-NOTA-trastuzumab for Targeted Radiotherapy in Primary and Metastatic HER2 + breast Cancer." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 202, 2026, p. 119736, https://doi.org/10.1016/j.biopha.2026.119736.